Hyperbaric oxygen as a treatment for COVID-19 infection?
Abstract
Recently the internet has been abuzz with new ideas to treat COVID-19, including hyperbaric
oxygen (HBO2) therapy, undoubtedly driven by the fact that until recently there have
been few therapeutic options for this highly contagious and often lethal infection.
. . . Refractory hypoxemia is certainly treatable with hyperbaric oxygen due to the
obvious effect of increasing inspired oxygen partial pressure (PO2), the major reason
for using HBO2 for its established indications. However, the length of time during
which patients can safely be administered HBO2 inside a chamber is limited, due to
practical issues of confinement and isolation from other necessary medical interventions,
but also because of oxygen toxicity.
Type
Journal articleSubject
HumansPneumonia, Viral
Coronavirus Infections
Oxygen
Pulmonary Gas Exchange
Hyperbaric Oxygenation
Middle Aged
Male
Pandemics
Hypoxia
Betacoronavirus
COVID-19
SARS-CoV-2
Permalink
https://hdl.handle.net/10161/22007Collections
More Info
Show full item recordScholars@Duke
Richard Edward Moon
Professor of Anesthesiology
Research interests include the study of cardiorespiratory function in humans exposed
to environmental conditions ranging from 200 feet of seawater depth to high altitude,
gas exchange during diving, the pathophysiology of high altitude pulmonary edema,
the effect of anesthesia and postoperative analgesia on pulmonary function and monitoring
of tissue oxygenation. Ongoing human studies include mechanisms of immersion pulmonary
edema and the effect of chemosensitivity on postoperative ventilation

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info